期刊文献+

宫外孕二号辨证加减联合米非司酮保守治疗异位妊娠的临床观察及干预效果 被引量:9

Clinical Observation on Dialectical Addition and Subtraction Ectopic Pregnancy 2 United Mifepristone in the Treatment of Ectopic Pregnancy
下载PDF
导出
摘要 目的:研究宫外孕二号辨证加减联合米非司酮保守治疗异位妊娠的临床效果。方法:选择130例输卵管异位妊娠患者作为研究对象,根据治疗方式分为给予宫外孕二号辨证加减联合米非司酮保守治疗的观察组和手术治疗的对照组,观察输卵管通畅情况、妊娠情况、生活质量以及负面情绪。结果:观察组输卵管通畅、妊娠、宫内妊娠的例数以及KPS评分、MUNSH评分、ESCA评分、总体生活质量均明显高于对照组;NRS评分、HAMD评分、HAMA评分明显低于对照组。结论:宫外孕二号辨证加减联合米非司酮保守治疗能够有效的改善治疗效果、提高生活质量,具有积极的临床价值。 Objective:To study dialectical addition and subtraction ectopic pregnancy 2 United mifepristone conserva- tive treatment for ectopic pregnancy clinical effect; Method:130 cases of tubal ectopic pregnancy patients were divided in- to dialectical addition and subtraction ectopic pregnancy 2 and subtraction United mifepristone conservative treatment group and operation treatment in the control group, observation of tubal patency, pregnancy, quality of life and negative emotions; Result: The observation group tubal patency, pregnancy, intrauterine pregnancy and KPS score, MUNSH score, ESCA score, the overall quality of life were significantly were significantly higher than those in the control group; NRS score, HAMD scores, HAMA score was significantly lower than the control group; Conclusion:dialectical addition and subtraction ectopic pregnancy 2 United mifepristone conservative treatment can effectively improve the effect of treat- ment, improve the quality of life, with a positive clinical value.
作者 周小飞
出处 《中华中医药学刊》 CAS 2013年第4期954-955,共2页 Chinese Archives of Traditional Chinese Medicine
关键词 异位妊娠 宫外孕二号 米非司酮 妊娠结局 Ectopic pregnancy Ectopic pregnancy 2 Mifepristone Pregnancy outcome
  • 相关文献

参考文献7

二级参考文献64

共引文献267

同被引文献106

  • 1高迎巧.中西药物保守治疗异位妊娠的研究进展[J].求医问药(下半月),2013(10):337-338. 被引量:3
  • 2王文慧,罗新.异位妊娠与卵巢疾病的鉴别诊断[J].实用妇产科杂志,2005,21(6):329-331. 被引量:8
  • 3余晓,俎德学,叶玲荣.血清孕酮和β-HCG测定在早期异位妊娠诊断中的价值[J].中国妇幼保健,2007,22(30):4309-4310. 被引量:22
  • 4Predunic M .Differentiating tubal abortion viable ectopicpregnancy withserum CA-125 and bet-human chorionic gonadotrop in deteminations[J].Fertil steril,2007,73(3) ; 522-525.
  • 5Lozezu A,Potter B .Diagnosis and management of ectopic pregnancyfj].Am Fam Physician, 2007,72 : 1707-1714.
  • 6郝雪冰.戴文玉.米非司酮联合宫外孕Ⅱ号方加减治疗输卵管妊娠临床分析[J].健康必读(中旬刊),2013,11(6):520-521.
  • 7郝雪冰,戴文玉.米非司酮联合宫外孕Ⅱ号方加减治疗输卵管妊娠临床分析[J].心理医生(下半月版),2012A(10):1306-1307.
  • 8Shaw J L V, Dey S K, Critchley H 0 D, et al. Current knowledge of the aetiology of human tubal ectopic pregnancy [ J ]. Human reproduction update,2010,16 (4) : 432 - 444.
  • 9Brown J K, Lauer K B, Ironmonger E L, et al. Shotgun proteomics identifies serum fibronectin as a candidate diagnostic biomarker for inclusion in future multiplex tests for ectopic pregnancy [ J ]. PloS one,2013,8(6) : 66974-66976.
  • 10Mine K, Yonezawa M, Ono S, et al. Analysis of risk factors asso- ciated with ectopic pregnancy after ART[J]. Fertility and Ste- rility,2013,100(3) : S513.

引证文献9

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部